20122023

Research activity per year

Network

Riekeld Scheper

Person: Academic

Ben Dijkmans

Person: Academic

Richard R. de Goeij-de Haas

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Rob Ruijtenbeek

  • Pamgene's Hertogenbosch
  • PamGene International BV

External person

Niccola Funel

  • University of Pisa

External person

Patrick Pauwels

  • University of Antwerp

External person

Adrienne H. Brouwers

  • University Medical Center Groningen
  • University Medical Center Groningen, Centre for Revalidation (Beatrix Children's Hospital)
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • Department of Obstetrics and Gynaecology

External person

Kaylee Keller

  • Vrije Universiteit Amsterdam

External person

E. G. E. de Vries

  • University of Groningen

External person

Suzanne J. A. Korporaal

  • University Medical Center Utrecht

External person

Harry J. Holland

  • University of Twente

External person

Girolamo Cirrincione

  • University of Palermo

External person

E. Boon

  • Radboud University Nijmegen

External person

Niek Bastiaensen

  • PamGene International BV, ‘S-Hertogenbosch, The Netherlands

External person

Iris D. Nagtegaal

  • Radboud University Medical Center
  • Radboud University Nijmegen

External person

R. van Haas

  • Heinrich Heine University Duesseldorf

External person

S.C. van Es

  • University of Groningen

External person

Naomi Parr

  • University Medical Center Utrecht

External person

Sue Ellen Verbrugge

  • VU Medisch Centrum

External person

Mark Roest

  • University Medical Center Utrecht
  • Utrecht University

External person

Patrizia Diana

  • University of Palermo

External person

Rik de Wijn

  • PamGene International BV, ‘S-Hertogenbosch, The Netherlands

External person

Richard de Goeij

  • Vrije Universiteit (VU) Amsterdam and VU Medical Center
  • Amsterdam UMC

External person

Silvie A. E. Sebastian

  • University Medical Center Utrecht

External person

Adam E. Frampton

  • Imperial College London
  • Hammersmith Hospital
  • University of Surrey

External person

Mirjam G.A. oude Egbrink

  • Maastricht University Medical Center
  • Maastricht University

External person

Wim J. G. Oyen

  • Radboud University Nijmegen
  • Institute of Cancer Research
  • European Organisation for Research and Treatment of Cancer Data Center
  • Radboud University Medical Center
  • Royal Marsden NHS Foundation Trust
  • Department of Obstetrics and Gynaecology

External person

Carla M L van Herpen

  • Radboud University Medical Center
  • Radboud University Nijmegen

External person

Srinivas Vanapalli

  • University of Twente

External person

Arnold C. Koekman

  • University Medical Center Utrecht

External person

A. A. Henneman

  • Amsterdam UMC - University of Amsterdam

External person

Theo van der Leij

  • PamGene International BV, ‘S-Hertogenbosch, The Netherlands

External person

Richard R. de Haas

  • Vrije Universiteit Amsterdam

External person

Filip Lardon

  • University of Antwerp

External person

S.G. Elias

  • Julius Health Care Centers

External person

Wim Trypsteen

  • Ghent University

External person

Richard R. de Goeij-de Haas

  • Amsterdam UMC - Vrije Universiteit Amsterdam

External person

Jose Koldenhof

  • University Medical Center Utrecht

External person

Sander R. Piersma

  • Amsterdam UMC - Vrije Universiteit Amsterdam
  • Amsterdam UMC

External person

Rob ter Heine

  • Radboud University Nijmegen

External person

Daniele V.F. Tauriello

  • Max Planck UCL Centre for Computational Psychiatry and Ageing Research
  • Institute for Research in Biomedicine

External person

Emile E. Voest

  • Utrecht University
  • Oncode Institute
  • Netherlands Cancer Institute

External person

Letizia Porcelli

  • IRCCS Istituto tumori Giovanni Paolo II - Bari

External person

Christian Rolfo

  • University of Antwerp
  • Antwerp University Hospital
  • University of Maryland, Baltimore

External person

Daniela Carbone

  • University of Palermo
  • Vrije Universiteit Amsterdam

External person

Thang V. Pham

  • Amsterdam UMC - Vrije Universiteit Amsterdam

External person

Adriënne van den Berg

  • PamGene International BV, ‘S-Hertogenbosch, The Netherlands

External person

Ietje Kathmann

  • Vrije Universiteit Amsterdam

External person

Dafne Carolina Alves Quixabeira

  • University of Helsinki

External person

Sjoerd G Elias

  • Utrecht University

External person

Peet Nooijen

  • Jeroen Bosch Ziekenhuis

External person

Suzanne C van Es

  • University of Groningen

External person

Arjan Barendrecht

  • University Medical Center Utrecht

External person

C. M. L. van Herpen

  • Radboud University Nijmegen

External person

Hans F. M. Pruijt

  • Jeroen Bosch Ziekenhuis

External person

Johan van Meerloo

  • VU University Medical Center
  • Vrije Universiteit Amsterdam
  • Amsterdam UMC

External person

Daniel S. K. Liu

  • Imperial College London

External person

Marjolein Y. V. Homs

  • Erasmus MC Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Cornelis Verhoef

  • Erasmus MC
  • Erasmus Universiteit Rotterdam

External person

Siamack Sabrkhany

  • Maastricht University Medical Center
  • Maastricht University

External person

Marcello Tiseo

  • University of Parma

External person

Christian D. Rolfo

  • Johns Hopkins University

External person

Joao Manuel Santos

  • University of Helsinki
  • TILT Biotherapeutics Ltd

External person

Sahil Jagga

  • University of Twente

External person

Stella Cascioferro

  • University of Palermo

External person

Barbara Parrino

  • University of Palermo

External person